Glenmark generics unit launches azathioprine in US
MUMBAI (Reuters) - Drugmaker Glenmark Pharmaceuticals Ltd said on Thursday its generics unit has launched azathioprine tablets in the United States.
Glenmark Generics Ltd acquired full marketing rights for the drug from an unnamed company, the company said in a statement.
Azathioprine is a generic version of Imuran, used to prevent rejection in kidney transplantation. It is also used to treat rheumatoid arthritis, Glenmark said in a statement.
Imuran had sales of about $36 million for the 12 months to June 2008, the company added.
© Thomson Reuters 2009 All rights reserved
Pledge to support economies
G20 financial leaders pledged to prepare strategies to end emergency support for their economies, but to keep the aid flowing until recovery was assured. Full Article | Related Story
Galleon case
U.S. insider trading probe widens
Fourteen people were charged with fraud and conspiracy in a dramatic widening of an insider trading scandal. Full Article
India
US
UK
